84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Brain Computer Interface Market to Reach USD 7,419.0 Mn by 2033; Amid Growing Research on Neural Interfaces and Cognitive Computing
February 13, 2024 06:37 ET | Market.Us
New York, Feb. 13, 2024 (GLOBE NEWSWIRE) -- According to Market.us, The Brain Computer Interface Market is projected to be worth USD 2,071.1 Million in 2023. The market is likely to reach USD...
22157.jpg
Neurotechnology Research Report 2024: Market Set to Surge, North America Leads Growth Trajectory - Long-term Forecast to 2028 and 2033
January 30, 2024 10:49 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Neurotechnology Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The report reveals that the neurotechnology...
Logo transparent PNG.png
PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device
September 14, 2023 06:00 ET | PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Zion Market Research.jpg
Global Brain-Computer Interface Market Size Astounding Growth to $6100 Billion by 2030, Growing at a CAGR of 16.5%
September 05, 2023 14:33 ET | Zion Market Research
New York, NY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Brain-Computer Interface Market By Product (Invasive BCI, Partially Invasive BCI,...
Logo transparent PNG.png
PathMaker Neurosystems Receives $200,000 START Award from MassVentures
June 05, 2023 06:00 ET | PathMaker Neurosystems Inc.
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
emotiv-logo-ol (2).png
EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain
May 01, 2023 09:00 ET | Emotiv Inc.
SAN FRANCISCO, May 01, 2023 (GLOBE NEWSWIRE) -- EMOTIV, the bioinformatics pioneer advancing understanding of the human brain using electroencephalography (EEG), today added two renowned scientists...
22157.jpg
Neurotech Devices Global Market Outlook Report 2023: Market Revenue Data for 2021, Estimates for 2022, 2023, 2025, and CAGR Projections through 2027
February 14, 2023 09:38 ET | Research and Markets
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "Neurotech Devices: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market is segmented based...
MyoRegulator® ALS device
Muscular Dystrophy Association Awards Venture Philanthropy Funding to PathMaker Neurosystems to Develop Neuromodulation Treatment for ALS
January 17, 2023 06:00 ET | PathMaker Neurosystems Inc.
BOSTON and NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company...
22157.jpg
Global Neurotechnology Market Report 2022: The Definitive Report on Neuromodulation, Neuroprosthetics, Neurodiagnostics, and Neurorehabilitation Devices
August 10, 2022 05:13 ET | Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "The Market for Neurotechnology: 2022-2026" report has been added to ResearchAndMarkets.com's offering. Overall worldwide market for neurotechnology...
22157.jpg
Global Invasive Brain-Computer interface (BCI) Market Research Report 2022: Real-time Decoding of Macroscopic Brain States Becomes Critical
June 14, 2022 05:43 ET | Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Market Overview of Invasive Brain-Computer interface (BCI)" report has been added to ResearchAndMarkets.com's offering. Patients with Locked-in...